Advanced in Metastatic Brain Tumor

Navneet K. Singh

Dilshad Garden, 
Delhi, DL, IN 
Advanced in Metastatic Brain Tumor
Dilshad Garden, 
Delhi, DL, IN 
OverviewLocationsClinical Research

Overview

Navneet Singh practices in Delhi, India. Ms. Singh is rated as an Advanced expert by MediFind in the treatment of Metastatic Brain Tumor. Her top areas of expertise are Lung Cancer, Non-Small Cell Lung Cancer (NSCLC), Small Cell Lung Cancer (SCLC), Endoscopy, and Synovectomy.

Her clinical research consists of co-authoring 506 peer reviewed articles and participating in 2 clinical trials. MediFind looks at clinical research from the past 15 years. In particular, she has co-authored 3 articles in the study of Metastatic Brain Tumor.

Gender
Female

Locations

Dilshad Garden, Delhi, DL 110095, India
Other Locations
Jalandhar Delhi G.T. Road, Phagwara, PB 144411, India
M.G. Ring Road, New Delhi, DL 110029, India
University Road, Meerut, UP 250004, India

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

2 Clinical Trials

A Study Assessing the Utility of Low-dose Computed Tomography (LDCT) in Lung Cancer Screening in North India
A Study Assessing the Utility of Low-dose Computed Tomography (LDCT) in Lung Cancer Screening in North India
Enrollment Status: Completed
Publish Date: March 29, 2022
Intervention Type: Diagnostic test
Study Phase: Not Applicable
A Randomized Study of the Safety and Efficacy of BIO-11006 in Treatment of Advanced Non-Small Cell Lung Cancer in Patients Who Are Not Candidates for Curative Surgery and/or Radiation and Who Are Receiving Pemetrexed and Carboplatin
A Randomized Study of the Safety and Efficacy of BIO-11006 in Treatment of Advanced Non-Small Cell Lung Cancer in Patients Who Are Not Candidates for Curative Surgery and/or Radiation and Who Are Receiving Pemetrexed and Carboplatin
Enrollment Status: Completed
Publish Date: May 19, 2020
Intervention Type: Drug
Study Phase: Phase 2
View 1 Less Clinical Trial

506 Total Publications

Mechanisms of Lung Crosstalk with End-Organs: Scientific Session V: ReSPIRE 2025.
Mechanisms of Lung Crosstalk with End-Organs: Scientific Session V: ReSPIRE 2025.
Journal: American journal of physiology. Lung cellular and molecular physiology
Published: August 21, 2025

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Ms. Singh's expertise for a condition
ConditionClose
    View All 9 Advanced Conditions
    View All 51 Experienced Conditions
    Want to save this expert for later?
    Sign Up
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn More
    Are you the provider on this profile?
    Claim Profile